Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Gynecol Oncol ; 166(3): 432-437, 2022 09.
Article in English | MEDLINE | ID: mdl-35817618

ABSTRACT

OBJECTIVE: The purpose of this study was to determine if laparoscopically guided transversus abdominis plane block (Lap-Tap) with liposomal bupivacaine provides superior postoperative pain control when compared to ultrasound-guided block (US-Tap) with liposomal bupivacaine at the time of robotic surgery for gynecology oncology patients. METHODS: This was a prospective randomized controlled trial assigning patients to one of two cohorts: Cohort 1 consisted of US-Tap administered before the procedure using liposomal bupivacaine, Cohort 2 consisted of Lap-Tap administration with laparoscopic visualization using the medication above. Primary outcomes were pain scores and total opioid use in Oral Morphine Equivalents (OME) during the first 72 h after surgery. Secondary outcomes were postoperative pain satisfaction and oral narcotic requirements. RESULTS: There was a significant increase in oral narcotic use in the first 24 h in the US-Tap cohort compared to the Lap-Tap cohort: Lap-Tap mean = 6.73 ± 8.22 OME versus US-Tap mean = 12.69 ± 12.94 p = 0.018 OME. The increase was equivalent to one additional Hydrocodone-Acetaminophen 7.5 mg/325 mg in the first 24 h after surgery. However, total oral narcotic use over the first 72 h was not significantly different between the two cohorts: Lap-Tap mean = 21.73 ± 19.83 OME, US-Tap mean = 32.50 ± 29.47, p = 0.062 OME. In addition, there was no significant difference in satisfaction or pain scores between the US-Tap and Lap-Tap groups at 24, 48, or 72-hours. CONCLUSIONS: Lap-Taps are comparable to US-Tap for postoperative analgesia during the first 72-h after surgery when performing robotic-assisted gynecologic oncology surgery.


Subject(s)
Genital Neoplasms, Female , Laparoscopy , Robotic Surgical Procedures , Abdominal Muscles/surgery , Analgesics, Opioid , Anesthetics, Local/therapeutic use , Bupivacaine/therapeutic use , Female , Genital Neoplasms, Female/surgery , Humans , Laparoscopy/methods , Morphine , Narcotics , Pain, Postoperative/drug therapy , Pain, Postoperative/etiology , Pain, Postoperative/prevention & control , Prospective Studies , Robotic Surgical Procedures/adverse effects , Robotic Surgical Procedures/methods
2.
J Trauma ; 60(3): 481-6; discussion 486-8, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16531843

ABSTRACT

BACKGROUND: The case-management team (CMT) has been an effective tool to decrease denied days and improve hospital throughput on a trauma service. With the addition of emergency general surgery (EGS) to our practice, we reviewed the ability of the case management team to absorb EGS patients on the inpatient trauma service while maintaining the improvements initially realized. METHODS: An interdisciplinary CMT was implemented in January 1999. CRNPs were added in August 2003 to address the Accreditation Council for Graduate Medical Education resident work-hour restrictions. "Key communications" for each CMT member are reported three times per week as defined by a hospital-approved policy. Beginning in August 2001, the trauma service was expanded to include EGS patients. Data from the trauma registry, hospital utilization review, and finance office were analyzed before (1998 and 1999) and after (2003 and 2004) the addition of EGS. Tests of proportion were used to evaluate questions of interest. RESULTS: The number of injured patients admitted to the trauma service remained relatively constant during the study periods, ranging from a high of 1,365 in 1999 to a low of 1,116 in 2003. Beginning in 2003, the influx of emergency surgery patients to the service was marked. By 2004, there were 561 emergency surgery admissions, representing more than 30% of the total service admissions. As a result, the total number of service admissions has dramatically increased, reaching 1,833 in CY 2004, a 56% increase from CY 1998 levels. Hospital length of stay data varied from a low of 5.5 days in CY 1999 to a high of 6.9 days in CY 2003. Length of stay appeared to be associated with injury severity (mean Injury Severity Score 11.8 in 1999 and 13.1 in 2003) and case mix, but not associated with denied days. The percent of denied days decreased over the study periods, from 4.6% in 1998 (before the implementation of the CMT) to 0.5% in 2004 (p<0.01). The percent of readmissions also fell significantly over the study periods (4.0% in 1998 to 1.8% in 2004; p<0.01). CONCLUSIONS: The initial improvements in patient throughput noted after the introduction of a CMT in January 1999 have been maintained in recent years despite the addition of an EGS component to the trauma service. Percent denied days and readmissions have continued to decrease. The length of stay for these patients remains, in part, dependent on other factors. The CMT plays an integral role in maintaining the efficiency of a trauma/emergency surgery service.


Subject(s)
Case Management/organization & administration , Emergency Service, Hospital/organization & administration , Patient Care Team/organization & administration , Surgery Department, Hospital/organization & administration , Trauma Centers/organization & administration , Wounds and Injuries/surgery , Adolescent , Adult , Aged , Communication , Cost-Benefit Analysis/organization & administration , Diagnosis-Related Groups/economics , Diagnosis-Related Groups/organization & administration , Emergency Service, Hospital/economics , Female , Financing, Personal/organization & administration , Humans , Injury Severity Score , Interprofessional Relations , Length of Stay/economics , Length of Stay/trends , Male , Middle Aged , Patient Care Team/economics , Surgery Department, Hospital/economics , Trauma Centers/economics , Workload/economics , Workload/statistics & numerical data
3.
J Neurosci Nurs ; 35(6): 327-31, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14713099

ABSTRACT

Since the discovery of a variant form of Creutzfeldt-Jakob disease (vCJD), the human form of bovine spongiform encephalopathy, researchers have been persistent in their search for the way in which this disease manifests itself in humans. Like all other forms of CJD, vCJD is a prion disease, or transmissible spongiform encephalopathy. The differences from other forms of CID are its manifestation and the population at risk. Diagnosing the disease remains a problem because true diagnosis can be determined only by postmortem evaluation. Because there is no treatment for vCJD or any form of CJD, palliative care is the foundation of care. Nurses should know the risks of the disease and understand its pathogenesis not only to explain modes of transmission to families but also to be able to protect themselves. Researchers are currently investigating a genetic link as well as the immunological relationship of this disease in hopes of providing more answers related to transmissibility, incubation, and risk for the disease.


Subject(s)
Creutzfeldt-Jakob Syndrome , Brain/pathology , Creutzfeldt-Jakob Syndrome/pathology , Creutzfeldt-Jakob Syndrome/physiopathology , Creutzfeldt-Jakob Syndrome/transmission , Diagnosis, Differential , Humans , Universal Precautions
SELECTION OF CITATIONS
SEARCH DETAIL
...